Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12613000384752
ACTRN12613000384752
Recruiting
Not Applicable

Hormonal responses and clinical outcome following three doses of gonadotropin-releasing hormone agonist used in short stimulation protocol in infertile patients undergoing in vitro fertilization cycles

Sarhan IVF Cntre0 sites90 target enrollmentApril 10, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInfertilityReproductive Health and Childbirth - Fertility including in vitro fertilisation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infertility
Sponsor
Sarhan IVF Cntre
Enrollment
90
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 10, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Sarhan IVF Cntre

Eligibility Criteria

Inclusion Criteria

  • •Infertile patients undergoing in vitrofertilization cycles,

Exclusion Criteria

  • •Patients with ovarian failure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermianon-obstructive azoospermia.Male infertility
IRCT201612069014N137Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences28
Recruiting
Phase 4
Prediction of Response Of horMOnal Treatment in advanced and recurrent Endometrial cancer
NL-OMON54286Radboud Universitair Medisch Centrum130
Completed
Phase 3
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric states
IRCT138809032766N1Tarbiat Maodares University150
Not yet recruiting
Not Applicable
The effects of neoadjuvant hormonal therapy on the course of PSA and testosterone in patients with low and intermediate risk prostate carcinoma (NEO-ONE)prostate carcinomaprostate cancer10038588
NL-OMON39212TweeSteden ziekenhuis400
Active, not recruiting
Not Applicable
The effects of pretreatment with androgen blocking hormones before brachytherapy for prostate cancer on the course of PSA and testosterone after treatmentocalized prostate cancerMedDRA version: 14.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-004749-41-NLTweeSteden hospital